Delcath Systems (DCTH) Cash from Investing Activities Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Delcath Systems | 383.27 Mn | 293.95 Mn | 21.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -129.34% |
| Dec 31, 2025 | -49.95% |
| Sep 30, 2025 | 0.88% |
| Jun 30, 2025 | -58.87% |
| Mar 31, 2025 | -168.56% |
| Dec 31, 2024 | -269.87% |
| Mar 31, 2024 | 371.57% |
| Dec 31, 2023 | -309.89% |
| Sep 30, 2023 | 15.44% |
| Jun 30, 2023 | -3.92% |
| Sep 30, 2022 | 6.66% |
| Jun 30, 2022 | 24.92% |
| Mar 31, 2022 | -8.94% |
| Dec 31, 2021 | 15.74% |
| Sep 30, 2021 | 20.38% |
| Jun 30, 2021 | 41.39% |
| Mar 31, 2021 | 9.71% |
| Dec 31, 2020 | -20.50% |
| Sep 30, 2020 | -63.25% |
| Jun 30, 2020 | -0.50% |
| Mar 31, 2020 | -31.95% |
| Dec 31, 2019 | 12.94% |
| Dec 31, 2018 | 10.13% |
| Sep 30, 2018 | 10.07% |
| Jun 30, 2018 | 6.01% |
| Mar 31, 2018 | 29.31% |
| Dec 31, 2017 | -28.14% |
| Sep 30, 2017 | 34.95% |
| Jun 30, 2017 | -15.68% |
| Mar 31, 2017 | -15.84% |
| Dec 31, 2016 | 61.70% |
| Sep 30, 2016 | 46.86% |
| Jun 30, 2016 | -12.63% |
| Mar 31, 2016 | -15.57% |
| Dec 31, 2015 | -27.83% |
| Sep 30, 2015 | -16.15% |